| PERIOD ENDING | 5-Jul-09 | 12-Apr-09 | 18-Jan-09 | 28-Sep-08 | | Total Revenue | 1,878,338 | 1,857,550 | 2,466,503 | 1,788,919 | | Cost of Revenue | 1,218,029 | 1,212,233 | 1,643,785 | 1,192,917 | | | Gross Profit | 660,309 | 645,317 | 822,718 | 596,002 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 552,422 | 557,224 | 736,574 | 531,143 | | Non Recurring | 28,972 | 18,440 | 19,141 | 42,310 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 78,915 | 69,653 | 67,003 | 22,549 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,326 | (639) | 1,841 | 1,267 | | Earnings Before Interest And Taxes | 80,241 | 69,014 | 68,844 | 23,816 | | Interest Expense | 7,688 | 7,696 | 13,580 | 8,303 | | Income Before Tax | 72,553 | 61,318 | 55,264 | 15,513 | | Income Tax Expense | 29,746 | 26,060 | 22,935 | 14,011 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 42,807 | 35,258 | 32,329 | 1,502 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,807 | 35,258 | 32,329 | 1,502 | | Preferred Stock And Other Adjustments | (7,839) | (7,934) | (4,533) |
-
| | | Net Income Applicable To Common Shares | $34,968 | $27,324 | $27,796 | $1,502 |
|
0.20% Nasdaq 
0.14%
Income Statement
